Myocardial Contraction
Myocardial Contraction - Related Videos
01:15
Muscle Contraction
0 Views •
2025
In skeletal muscles, acetylcholine is released by nerve terminals at the motor end plate—the point of synaptic communication between motor neurons and muscle fibers. Binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive muscle...
01:10
Muscle Contraction
0 Views •
2023
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive muscle...
02:08
Assessing Muscle Contraction with Neuromuscular Blocker Treatment
0 Views •
2025
This video demonstrates assessing the muscle using cultured motor neurons, Schwann cells, and myotubes, followed by treatment with a neuromuscular blocker to inhibit contraction. Color-coded time-motion graphics show a color-coded time-motion graphic. Red indicates the fastest movement, and blue indicates the slowest.
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
0 Views •
Cited by 13 •
2017
We present three novel and more efficient protocols for differentiating human induced pluripotent stem cells into cardiomyocytes, endothelial cells, and smooth muscle cells and a delivery method that improves the engraftment of transplanted cells by combining cell injection with patch-mediated cytokine delivery.
11:38
Preparation of Complaint Matrices for Quantifying Cellular Contraction
0 Views •
Cited by 115 •
2010
In this video, we demonstrate the experimental techniques used to fabricate compliant, extracellular matrix (ECM) coated substrates suitable for cell culture, and which are amenable to traction force microscopy and observing effects of ECM stiffness on cell behavior.
FAQs
The action potential opens L-type calcium channels in cardiomyocytes, allowing calcium to enter the cell. This entry promotes additional calcium release from the sarcoplasmic reticulum, increasing the calcium available to regulate the contractile machinery. Calcium then binds troponin, enabling actin-myosin cross-bridge cycling and the development of force. This sequence connects electrical excitation with mechanical output.
These components contribute at successive stages of calcium handling. L-type calcium channels provide the initial calcium entry triggered by the action potential, while the sarcoplasmic reticulum serves as a source for additional calcium release. Considering both steps helps explain how pharmacological changes in calcium handling can alter the strength of cardiac contraction rather than affecting electrical activity alone.
Troponin acts as the calcium-responsive element that links intracellular calcium availability to the contractile apparatus. Once calcium binds to troponin, actin-myosin cross-bridge cycling can proceed, producing force. This position makes troponin an important mechanistic point for understanding how changes in calcium concentration are translated into altered myocardial contraction.
Positive inotropic effects increase contractile force, whereas negative inotropic effects reduce it. Pharmacologically, these changes can arise from interventions that modify calcium handling, adrenergic signaling, or other determinants of contractile force. Distinguishing the direction of the inotropic response helps researchers interpret how a drug may influence cardiac pumping performance in cardiovascular disease studies.
A mechanistic investigation can follow the sequence from action-potential activity to L-type calcium entry, sarcoplasmic-reticulum calcium release, troponin binding, and cross-bridge cycling. Researchers can then relate an intervention to calcium handling, adrenergic signaling, or force development. This framework helps connect a drug’s site of action with its resulting positive or negative inotropic effect.
Contractile force depends on coordinated electrical signaling and calcium regulation, so altered contraction can be examined through these linked processes. Pharmacological studies can evaluate agents that change calcium handling, adrenergic signaling, or contractile strength. This mechanistic context supports investigation of therapies for heart failure and arrhythmias, as well as hypertension and other cardiovascular disorders.